Activation of the Nrf2 Signaling Pathway as a Therapeutic Strategy Against Periodontal Disease: A Narrative Review
- PMID: 40710159
- PMCID: PMC12293358
- DOI: 10.3390/dj13070314
Activation of the Nrf2 Signaling Pathway as a Therapeutic Strategy Against Periodontal Disease: A Narrative Review
Abstract
Periodontitis (PD), is a chronic inflammatory disease of the periodontal system, which includes gingiva, periodontal ligament, alveolar bone, and tooth cement. It is becoming increasingly prevalent globally, and its implications for oral health are profound. The Nrf2 signaling pathway is crucial in managing the relationship between inflammation and oxidative stress, making it vital for understanding this disease. Nrf2 interacts with key redox-sensitive inflammatory pathways, playing a vital role in the development of periodontitis. Acknowledging these dynamics underscores the importance of proactively addressing the complex aspects of periodontal disease. This review emphasizes its intricate interactions with redox-sensitive transcription factors vital for sustaining the self-perpetuating inflammatory processes underlying the disease. Additionally, it explores promising therapeutic strategies aimed at Nrf2 activation and encourages more effective management of PD.
Keywords: Nrf2; oxidative stress; periodontitis; pharmacotherapy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Guided tissue regeneration for periodontal infra-bony defects.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001724. doi: 10.1002/14651858.CD001724.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 May 29;5:CD001724. doi: 10.1002/14651858.CD001724.pub3. PMID: 16625546 Updated.
-
Bmi-1 alleviates alveolar bone resorption through the regulation of autophagy.J Periodontol. 2025 Jun;96(6):694-707. doi: 10.1002/JPER.23-0796. Epub 2024 Sep 23. J Periodontol. 2025. PMID: 39311723
-
Effect of single-visit full-mouth non-surgical therapy and risk factor analysis on long-term periodontal treatment outcomes: aretrospective study.Clin Oral Investig. 2025 Jun 5;29(6):333. doi: 10.1007/s00784-025-06405-2. Clin Oral Investig. 2025. PMID: 40468146 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Supportive periodontal therapy (SPT) for maintaining the dentition in adults treated for periodontitis.Cochrane Database Syst Rev. 2018 Jan 1;1(1):CD009376. doi: 10.1002/14651858.CD009376.pub2. Cochrane Database Syst Rev. 2018. PMID: 29291254 Free PMC article.
References
-
- Giannini G., Ragusa I., Nardone G.N., Soldi S., Elli M., Valenti P., Rosa L., Marra E., Stoppoloni D., Pich E.M., et al. Probiotics-containing mucoadhesive gel for targeting the dysbiosis associated with periodontal diseases. Int. J. Dent. 2022;2022:5007930. doi: 10.1155/2022/5007930. - DOI - PMC - PubMed
-
- Caton J.G., Armitage G., Berglundh T., Chapple I.L.C., Jepsen S., Kornman K.S., Mealey B.L., Papapanou P.N., Sanz M., Tonetti M.S. A new classification scheme for periodontal and peri-implant diseases and conditions—Introduction and key changes from the 1999 classification. J. Clin. Periodontol. 2018;45((Suppl. 20)):S1–S8. doi: 10.1111/jcpe.12935. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources